AR066373A1 - Formulaciones de aminoacidos n-halogenados - Google Patents
Formulaciones de aminoacidos n-halogenadosInfo
- Publication number
- AR066373A1 AR066373A1 ARP080101844A ARP080101844A AR066373A1 AR 066373 A1 AR066373 A1 AR 066373A1 AR P080101844 A ARP080101844 A AR P080101844A AR P080101844 A ARP080101844 A AR P080101844A AR 066373 A1 AR066373 A1 AR 066373A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxide
- transfer agent
- phase transfer
- halogenated
- formulations
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- IBWGNZVCJVLSHB-UHFFFAOYSA-M tetrabutylphosphanium;chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CCCC IBWGNZVCJVLSHB-UHFFFAOYSA-M 0.000 abstract 2
- LPSKDVINWQNWFE-UHFFFAOYSA-M tetrapropylazanium;hydroxide Chemical compound [OH-].CCC[N+](CCC)(CCC)CCC LPSKDVINWQNWFE-UHFFFAOYSA-M 0.000 abstract 2
- NMMHHSLZJLPMEG-UHFFFAOYSA-N 2-(chloroamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCNCl NMMHHSLZJLPMEG-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 150000001412 amines Chemical group 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 abstract 1
- OJQAVLJZQFBRLC-UHFFFAOYSA-M dodecyl(triethyl)azanium;hydroxide Chemical compound [OH-].CCCCCCCCCCCC[N+](CC)(CC)CC OJQAVLJZQFBRLC-UHFFFAOYSA-M 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/14—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-halogen bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/04—Sulfonic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Environmental Sciences (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91529107P | 2007-05-01 | 2007-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066373A1 true AR066373A1 (es) | 2009-08-12 |
Family
ID=39596568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101844A AR066373A1 (es) | 2007-05-01 | 2008-04-30 | Formulaciones de aminoacidos n-halogenados |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080275123A1 (enExample) |
| EP (1) | EP2139518A1 (enExample) |
| JP (1) | JP2010526082A (enExample) |
| KR (1) | KR20100017166A (enExample) |
| CN (1) | CN101674849A (enExample) |
| AR (1) | AR066373A1 (enExample) |
| AU (1) | AU2008245455A1 (enExample) |
| BR (1) | BRPI0810790A2 (enExample) |
| CA (1) | CA2684098A1 (enExample) |
| CL (1) | CL2008001279A1 (enExample) |
| MX (1) | MX2009011819A (enExample) |
| RU (1) | RU2009144292A (enExample) |
| TW (1) | TW200902093A (enExample) |
| UY (1) | UY31059A1 (enExample) |
| WO (1) | WO2008134687A1 (enExample) |
| ZA (1) | ZA200907050B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY31058A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios |
| EP2265267B1 (en) | 2008-04-10 | 2016-09-21 | Waldemar Gottardi | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
| WO2009127924A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
| CN102176818A (zh) * | 2008-08-12 | 2011-09-07 | 诺华贝制药公司 | 抗微生物凝胶制剂 |
| WO2010091280A1 (en) * | 2009-02-06 | 2010-08-12 | Alcon Research, Ltd. | N-halogenated amino acid formulations comprising phosphine or amine oxides |
| CN102625558B (zh) * | 2012-03-30 | 2014-09-03 | 安徽航天环境工程有限公司 | 带有冷却系统的等离子体加热器 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2003198C (en) * | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5320805A (en) * | 1991-05-15 | 1994-06-14 | Sterilex Corporation | Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| US5968986A (en) * | 1997-12-18 | 1999-10-19 | Woodward Laboratories, Inc. | Antimicrobial nail coating composition |
| US6759434B2 (en) * | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
| PL1656095T3 (pl) * | 2003-08-18 | 2014-04-30 | Novabay Pharmaceuticals Inc | N,n-dwuchlorowcowane kwasy aminowe i pochodne |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
-
2008
- 2008-04-29 UY UY31059A patent/UY31059A1/es not_active Application Discontinuation
- 2008-04-30 TW TW097115865A patent/TW200902093A/zh unknown
- 2008-04-30 MX MX2009011819A patent/MX2009011819A/es unknown
- 2008-04-30 EP EP08769241A patent/EP2139518A1/en not_active Withdrawn
- 2008-04-30 KR KR1020097024173A patent/KR20100017166A/ko not_active Withdrawn
- 2008-04-30 BR BRPI0810790-4A patent/BRPI0810790A2/pt not_active IP Right Cessation
- 2008-04-30 WO PCT/US2008/061942 patent/WO2008134687A1/en not_active Ceased
- 2008-04-30 JP JP2010506582A patent/JP2010526082A/ja not_active Withdrawn
- 2008-04-30 AR ARP080101844A patent/AR066373A1/es not_active Application Discontinuation
- 2008-04-30 AU AU2008245455A patent/AU2008245455A1/en not_active Abandoned
- 2008-04-30 US US12/112,384 patent/US20080275123A1/en not_active Abandoned
- 2008-04-30 CN CN200880014117A patent/CN101674849A/zh active Pending
- 2008-04-30 RU RU2009144292/15A patent/RU2009144292A/ru not_active Application Discontinuation
- 2008-04-30 CA CA002684098A patent/CA2684098A1/en not_active Abandoned
- 2008-05-02 CL CL2008001279A patent/CL2008001279A1/es unknown
-
2009
- 2009-10-09 ZA ZA2009/07050A patent/ZA200907050B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2684098A1 (en) | 2008-11-06 |
| RU2009144292A (ru) | 2011-06-10 |
| CN101674849A (zh) | 2010-03-17 |
| UY31059A1 (es) | 2008-10-31 |
| WO2008134687A1 (en) | 2008-11-06 |
| MX2009011819A (es) | 2009-11-13 |
| TW200902093A (en) | 2009-01-16 |
| US20080275123A1 (en) | 2008-11-06 |
| ZA200907050B (en) | 2010-12-29 |
| BRPI0810790A2 (pt) | 2015-06-16 |
| JP2010526082A (ja) | 2010-07-29 |
| AU2008245455A1 (en) | 2008-11-06 |
| CL2008001279A1 (es) | 2009-01-02 |
| EP2139518A1 (en) | 2010-01-06 |
| KR20100017166A (ko) | 2010-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR066373A1 (es) | Formulaciones de aminoacidos n-halogenados | |
| MX2016000307A (es) | Farmaco para el tratamiento de la esteatosis hepatica no alcoholica. | |
| BRPI0407658A (pt) | derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico | |
| EA200900959A1 (ru) | Ингибиторы мек | |
| BR112013020132A2 (pt) | lenço para uso com uma solução germicida e método para desinfetar uma superfície | |
| BRPI0412054A (pt) | preparação farmacêutica transdérmica | |
| NZ700761A (en) | Salt form of a human histone methyltransferase ezh2 inhibitor | |
| NO20092535L (no) | Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol | |
| SA519402090B1 (ar) | مثبطات انتقائية لـ hdac6، وطريقة تحضيرها، واستخدامها | |
| MX2021007161A (es) | Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia. | |
| JOP20210338A1 (ar) | نظائر 3-(5-مثيل-3،1- ثيازول-2- يل)-n-{(1r)-1-[2-(تراي فلورومثيل) بيريميدين-5-يل] إثيل} بنزاميد | |
| JOP20190053A1 (ar) | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط | |
| BR0308133A (pt) | Forma polimórfica cristalina de cloridrato de irinotecan | |
| AR081973A1 (es) | Composiciones y metodos para incrementar la reduccion de microorganismos formadores de esporas | |
| BRPI0410837A (pt) | composto, composição farmacêutica, e, método para tratar ou prevenir uma doença ou condição | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
| TW200724166A (en) | Wrinkle-improving agent | |
| AR066372A1 (es) | Formulaciones de aminoacidos n-halogenados con compuestos antiinflamatorios | |
| EA200901141A1 (ru) | Соли присоединения с кислотами, гидраты и полиморфные формы этидамида 5-(2,4-дигидрокси-5-изопропилфенил)-4-(4-морфолин-4-илметилфенил)изоксазол-3-карбоновой кислоты и препараты, содержащие эти формы | |
| EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
| AR068307A1 (es) | Formulaciones de aminoacidos n-halogenados y metodos para la limpieza y desinfeccion | |
| BR112022008457A2 (pt) | Agente terapêutico e agente profilático para distúrbios gastrointestinais funcionais e xerostomia | |
| MX2019014201A (es) | Composicion farmaceutica y forma de dosificacion farmaceutica que comprenden (e)-4-(2-(aminometil)-3-fluoroaliloxi)-n-ter-butilbenza mida, proceso para su preparacion, metodos de tratamiento y usos de las mismas. | |
| UY27910A1 (es) | Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |